Facebook
Twitter
LinkedIn
Forward
Spotlight on Advanced Topics in Women’s Mental Health (September 2022)
Registration Deadline: October 3, 2022
The purpose of this course is to provide clinically meaningful education to multidisciplinary health care providers on topics often encountered in caring for women with psychiatric disorders. This course was designed to promote high quality clinical care in women with psychiatric disorders across the reproductive lifespan, with comprehensive coverage of frequently encountered topics and discussion of the evidence base to inform clinical decision making. Perinatal psychiatry topics will including clinical challenges discussed with case-based learning and considerations for women of color. Substance use disorders during pregnancy and the postpartum will be additionally addressed. Topics will also include sexual dysfunction and an update on hormone therapy for the menopausal transition. Learning in this course will be facilitated by didactic materials delivered by the faculty from the MGH Center for Women’s Mental Health. Faculty will also provide question and answer and case-based discussion sessions for course participants. Readings to accompany course materials will also be provided.
Participants will have access to course materials from September 19, 2022 to November 7, 2022.
Pricing
Registration Deadline: October 3, 2022
Physicians and Doctoral-level Professionals: $445.00
Other Professionals: $345.00
Restriction on Use of Materials
This site is operated and maintained by The Massachusetts General Hospital Psychiatry Academy. No material or information from this site may be copied, reproduced, republished, uploaded, posted, transmitted or distributed unless approved in writing by The Psychiatry Academy. Questions concerning the proper use of materials and information in this site should be directed to: mghcme@mgh.harvard.edu. No rights or licenses of any kind of The Psychiatry Academy’s intellectual property are transferred to, granted to, provided to or received by you as a result of using this web site.
Cancellation Policy
Refunds will be issued for cancellation requests made during the first week of the course, but an administrative fee of $25.00 will be deducted from your refund. Cancellation requests made during the second week will receive a credit toward a future offering of the same course. No refunds or credits will be granted after October 3, 2022.
Q&A with Faculty
Welcome to Spotlight on Advanced Topics in Women’s Mental Health.
Each week, the faculty will be answering questions relating to the webinars and readings.
Please prepare your questions in advance of the call and submit them to womensmentalhealth@mgh.harvard.edu. If time permits, you may be able to ask questions that have not been pre-submitted, but to guarantee your query is addressed please send in your questions by close of business the day prior.
Date & Time of Q/A | Faculty | Topic | ||
|---|---|---|---|---|
Tuesday (9/20) at 1:00PM EDT | Lee Cohen | Challenging Cases in Perinatal Psychiatry: Case Based Learning I | ||
Tuesday (9/27) at 1:00PM EDT | Marlene Freeman | Challenging Cases in Perinatal Psychiatry: Case Based Learning II | ||
Friday (10/7) at 12:00PM EDT | Nkechi Conteh | Perinatal Psychiatry: Considerations for Women of Color | ||
Tuesday (10/11) at 11:00AM EDT | Jan Shifren | Sexual Dysfunction in Women: Causes and Treatment Options | ||
Monday (10/17) at 3:00PM EDT | Kathryn Martin | Menopausal Hormone Therapy: Benefits and Risks Revisited | ||
Friday (10/28) at 2:00PM EDT | Jessica Gray | Substance Use Disorders During Pregnancy and the Postpartum |
Target Audience
This program is intended for: practicing psychiatrists, primary care physicians, psychologists and nurse practitioners.
Learning Objectives
Challenging Cases 1:
- Discuss the management of psychiatric disorders in women in the context of infertility and its treatment
- Describe FDA pregnancy labeling for psychotropic medications and to put this in historical context, while considering the use of an antidepressant and early pregnancy exposure
- Discuss selected non-medication strategies as part of the regimen for residual major depressive disorder
Challenging Cases 2:
- Discuss the prevalence of postpartum psychosis and its risk factors, treatment and prevention strategies
- Discuss treatment for bipolar disorder across pregnancy and the postpartum and relapse prevention strategies
- Discuss the impact of the COVID-19 pandemic on the clinical delivery of perinatal psychiatry services in the US
- Describe the risks of obesity in pregnancy and implications for women with psychiatric disorders
Considerations for Women of Color:
- Identify barriers to care for racially and ethnically minoritized women.
- Discuss factors associated with the development of medical mistrust.
- Describe the cultural assessment and treatment preferences of racially and ethnically minoritized women.
Sexual Dysfunction in Women
- Assess the various causes of sexual problems for women
- Discuss risks and benefits of available treatment options for sexual dysfunction in women
- Create an individualized treatment plan that addresses the multi-factorial nature of sexual dysfunction
Menopausal Hormone Therapy:
- Discuss the impact of menopausal symptoms on quality of life
- Describe how to advise women about available therapies for vasomotor symptoms
- Assess the potential risks and benefits of menopausal hormone therapy
Substance Use Disorder During Pregnancy:
- Describe how the historical approach to substance use in pregnancy continues to harm patients in the U.S.
- Discuss the optimal management of pregnant people who use opioids
- Describe the literature on treatment of alcohol use disorder in pregnancy
Participants must complete each week and must complete all components receive credit, including:
- Video Lecture
- Reading and Resources (required and optional)
- Q&A with Faculty
- Discussion Board
- Quiz
Speaker | Topic |
Lee Cohen and Marlene Freeman | Challenging Cases in Perinatal Psychiatry: Case Based Learning I & II |
Nkechi Conteh | Perinatal Psychiatry: Considerations for Women of Color |
Jan Shifren | Sexual Dysfunction in Women: Causes and Treatment Options |
Kathryn Martin | Menopausal Hormone Therapy: Benefits and Risks Revisited |
Jessica Gray | Substance Use Disorders During Pregnancy and the Postpartum |
Faculty Question and Answer Call Schedule:
Date & Time of Q/A | Faculty | Topic |
|---|---|---|
Tuesday (9/20) at 1:00PM EDT | Lee Cohen | Challenging Cases in Perinatal Psychiatry: Case Based Learning I |
Tuesday (9/27) at 1:00PM EDT | Marlene Freeman | Challenging Cases in Perinatal Psychiatry: Case Based Learning II |
Friday (10/7) at 12:00PM EDT | Nkechi Conteh | Perinatal Psychiatry: Considerations for Women of Color |
Tuesday (10/11) at 11:00AM EDT | Jan Shifren | Sexual Dysfunction in Women: Causes and Treatment Options |
Monday (10/17) at 3:00PM EDT | Kathryn Martin | Menopausal Hormone Therapy: Benefits and Risks Revisited |
Friday (10/28) at 2:00PM EDT | Jessica Gray | Substance Use Disorders During Pregnancy and the Postpartum |
Available Credit
- 13.50 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 13.50 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 13.50 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 13.50 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 13.50 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 13.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 91038
- 13.50 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 13.50 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 13.50 Continuing Education (CE) credits per presentation for psychologists.
Price
Course Director(s)
Lee Cohen, MD
Marlene Freeman, MD
Planners
David H. Rubin, MD, reviewer
Jane Pimental, MPH
Susan E. Sprich, PhD, psychologist reviewer
Lee Cohen, MD
Marlene Freeman, MD
Disclosure Information
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:
Ineligible Companies
The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” For more information, visit
Financial Relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.
The following planners, speakers, content reviewers, and others in control of educational content have reported financial relationships with ineligible companies over the past 24 months. Measures have been taken to mitigate the impact of these financial relationships on the educational content and ensure that they do not insert commercial bias into the content of this education.
Marlene P. Freeman, MD
Investigator Initiated Trials (Research): JayMac, Sage
Advisory Board: Otsuka, Alkermes, Sunovion Pharmaceuticals
Independent Data Safety and Monitoring Committee (Honoraria): Janssen (Johnson& Johnson)
Dr. Freeman is an employee of Massachusetts General Hospital, and works with the MGH National Pregnancy Registry [Current Registry Sponsors]: Teva, Alkermes, Inc., Otsuka America Pharmaceutical, Inc., Forest/Actavis, Sunovion Pharmaceuticals, Inc.
Steering Committee for Educational Activities: Medscape
Lee S. Cohen, PhD
Research Support: National Pregnancy Registry for Psychiatric medications, Alkermes Biopharmaceuticals ; Aurobindo Pharma; Auromedics Pharma LLC; Janssen Pharmaceutica; Otsuka Pharmaceuticals, Inc; Supernus Pharmaceuticals
Other Research Support: Brain & Behavior Research Foundation; JayMac Pharmaceuticals; National Institute on Aging; National Institutes of Health; SAGE Therapeutics
Advisory/Consulting (through MGH Clinical Trials Network Initiative): Alkermes Biopharmaceuticals; Praxis Precision Medicines, Inc.
Jessica Gray, MD
Consultant: MCSTAP Massachusetts Consultaiton Service for Treatment of Addiction and Pain
Expert Witness: Vermont office of Attorney General
Consultant/on-call medical coverage: Gavin Foundation; Bay Cove
NIDA CTN 0800 study physician - salary support: NIDA
Susan Sprich, PhD
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honoraria (Associate Editors): Association for Behavioral and Cognitive Therapies (ABCT)
All other individuals in a position to control the content of this educational activity have reported no financial relationships with ineligible companies.
Hardware/Software Specifications
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements
Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit
Privacy Policy
Please click here to review our privacy policy.